Literature DB >> 1546298

Reversal of diabetes insipidus in Brattleboro rats: intrahypothalamic injection of vasopressin mRNA.

G F Jirikowski1, P P Sanna, D Maciejewski-Lenoir, F E Bloom.   

Abstract

Messenger RNAs occur within the axons of magnocellular hypothalamic neurons known to secrete oxytocin and vasopressin. In Brattleboro rats, which have a genetic mutation that renders them incapable of vasopressin expression and secretion and thus causes diabetes insipidus, injection into the hypothalamus of purified mRNAs from normal rat hypothalami or of synthetic copies of the vasopressin mRNA leads to selective uptake, retrograde transport, and expression of vasopressin exclusively in the magnocellular neurons. Temporary reversal of their diabetes insipidus (for up to 5 days) can be observed within hours of the injection. Intra-axonal mRNAs may represent an additional category of chemical signals for neurons.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1546298     DOI: 10.1126/science.1546298

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  63 in total

1.  mRNA: Fulfilling the Promise of Gene Therapy.

Authors:  Drew Weissman; Katalin Karikó
Journal:  Mol Ther       Date:  2015-09       Impact factor: 11.454

2.  Structurally Programmed Assembly of Translation Initiation Nanoplex for Superior mRNA Delivery.

Authors:  Jiahe Li; Wade Wang; Yanpu He; Yingzhong Li; Emily Z Yan; Ketian Zhang; Darrell J Irvine; Paula T Hammond
Journal:  ACS Nano       Date:  2017-02-14       Impact factor: 15.881

3.  Business: The billion-dollar biotech.

Authors:  Elie Dolgin
Journal:  Nature       Date:  2015-06-04       Impact factor: 49.962

Review 4.  mRNA: A Novel Avenue to Antibody Therapy?

Authors:  Thomas Schlake; Moritz Thran; Katja Fiedler; Regina Heidenreich; Benjamin Petsch; Mariola Fotin-Mleczek
Journal:  Mol Ther       Date:  2019-03-06       Impact factor: 11.454

5.  Rat hypothalamus neuron-like cells in primary culture accumulate and translate mRNA coding for the amphibian P-domain peptide xP1.

Authors:  J C Probst; G F Jirikowski; T Skutella; H Vedder
Journal:  Cell Mol Neurobiol       Date:  1997-06       Impact factor: 5.046

Review 6.  mRNA-based therapeutics--developing a new class of drugs.

Authors:  Ugur Sahin; Katalin Karikó; Özlem Türeci
Journal:  Nat Rev Drug Discov       Date:  2014-09-19       Impact factor: 84.694

Review 7.  mRNA vaccines - a new era in vaccinology.

Authors:  Norbert Pardi; Michael J Hogan; Frederick W Porter; Drew Weissman
Journal:  Nat Rev Drug Discov       Date:  2018-01-12       Impact factor: 84.694

Review 8.  RNA in the axonal domain: a new dimension in neuronal functioning?

Authors:  J Van Minnen
Journal:  Histochem J       Date:  1994-05

9.  Organ-targeted high-throughput in vivo biologics screen identifies materials for RNA delivery.

Authors:  Tsung-Yao Chang; Peng Shi; Joseph D Steinmeyer; Itthi Chatnuntawech; Paul Tillberg; Kevin T Love; Peter M Eimon; Daniel G Anderson; Mehmet Fatih Yanik
Journal:  Integr Biol (Camb)       Date:  2014-09-03       Impact factor: 2.192

10.  Cellular and subcellular evidence for neuronal interaction between the chemokine stromal cell-derived factor-1/CXCL 12 and vasopressin: regulation in the hypothalamo-neurohypophysial system of the Brattleboro rats.

Authors:  Céline Callewaere; Brigitte Fernette; Danièle Raison; Patricia Mechighel; Arlette Burlet; André Calas; Patrick Kitabgi; Stéphane Mélik Parsadaniantz; William Rostène
Journal:  Endocrinology       Date:  2007-09-27       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.